Chronic kidney disease: No significant effect of cinacalcet on cardiovascular outcomes in patients undergoing dialysis - EVOLVE results

Nature Reviews Nephrology

Volumn 9, Issue 1, 2013, Pages 4-

  Carney, Ellen F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CINACALCET; PHOSPHATE BINDING AGENT; PLACEBO; VITAMIN D DERIVATIVE;

BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CHRONIC KIDNEY DISEASE; DEATH; FRACTURE; HEMODIALYSIS PATIENT; HUMAN; HYPOCALCEMIA; NOTE; PARATHYROIDECTOMY; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM;

EID: 84871620146     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2012.258     Document Type: Note

References (1)

1. The EVOLVE Trial Investigators. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N. Engl. J. Med. doi:10.1056/ NEJMoa1205624